CARDIORENTIS
Cardiorentis is a privately owned biopharmaceutical company designed for the new world of drug development. Focused, fast moving and flexible, with patients at its heart, Cardiorentis AG is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases.Cardiorentis fuses superior science and pharmaceutical intelligence, offering a company with a genuine thirst for scientific advancement, but with the practical know-how to be able to bring products to ... the market and enhance the lives of patients. With a notable expertise in cardiology, Cardiorentis AG is initially concentrating its efforts on ularitide for the treatment of acute cardiovascular indications, with the aim of developing the first evidence-based drug treatment for acute heart failure (AHF).Cardiorentis is proud of the strong partnerships it has built with academic researchers, universities and practicing clinicians across the world; all working closely together to drive important research forward. United by their common goal, they believe that their actions today will shape the future of patient care tomorrow.
CARDIORENTIS
Industry:
Biopharma Biotechnology Health Care
Founded:
2010-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.cardiorentis.com
Total Employee:
1+
Status:
Closed
Contact:
+41 41 748 60 30
Email Addresses:
[email protected]
Total Funding:
118.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag
Current Employees Featured
Founder
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Series A - Cardiorentis
Official Site Inspections
http://www.cardiorentis.com
- Host name: dali.sui-inter.net
- IP address: 80.74.145.65
- Location: Neunkirch Switzerland
- Latitude: 47.6901
- Longitude: 8.4998
- Timezone: Europe/Zurich
- Postal: 8213
